IP Library Granted Patent US 7,205,116
Granted Patent B2
US 7,205,116 · App. 11/345,706 · Granted Apr 17, 2007

5-Fluoro-uracil immunoassay

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,205,116
App. No.
11/345,706
Granted
Apr 17, 2007
Kind
B2
Abstract

Novel conjugates of 5-fluoro-uracil and novel 5-fluoro-uracil immunogens and monoclonal antibodies generated by these immunogens which are useful in immunoassays for the quantification and monitoring of 5-fluoro-uracil in biological fluids.

Claims (25)

1. A process for performing an immunoassay for detecting 5-fluoro-uracil in a sample comprising providing a mixture of a) a sample, b) an antibody selectively reactive with 5-fluoro-uracil which antibody is not substantially cross-reactive with tegafur and c) a conjugate of a carrier with a compound of the formula:

wherein Y is an organic spacing group;

X is a terminal functional group capable of binding to the carrier; and

p is an integer from 0 to 1

or a compound of the formula:

wherein X, Y and p are as above;

or mixtures thereof;

causing the 5-fluoro-uracil in the sample and said conjugate to bind with said antibody and thereafter measuring the amount of said conjugate in said mixture which is bound or unbound to said antibody whereby the presence of 5-fluoro-uracil in the sample can be determined.

2. The process of claim 1 , wherein the sample is a human sample.

3. The process of claim 2 , wherein said antibody is generated from an immunogen comprising an immunogenic carrier containing a polyamine polymer conjugated with a compound of the formula:

wherein p, X and Y are as above.

4. The process of claim 2 , wherein the antibody is attached to a solid support.

5. The process of claim 4 , wherein the solid support is a microtitor plate.

6. The process of claim 4 , wherein the solid support is nanoparticles.

7. A kit for determining the presence of 5-fluoro-uracil in a patient sample comprising reagents in separate containers, one of the reagents being a conjugate of a carrier with a compound of the formula:

wherein Y is an organic spacing group;

X is a terminal functional group capable of binding to a carrier; and

p is an integer from 0 to 1;

or a compound of the formula:

wherein X, Y and p are as above;

or mixtures thereof; and the second container containing an antibody substantially selectively reactive with 5-fluoro-uracil and not substantially cross-reactive to tegafur or uracil.

8. The kit of claim 7 , wherein said conjugate is present in a predetermined amount in said first container.

9. The kit of claim 8 , wherein said kit is used to determine the amount of 5-fluoro-uracil in said sample.

10. The kit of claim 7 , wherein, said antibody is generated from an immunogen of an immunogenic polyamine polypeptide linked to a compound of the formula:

wherein p, X and Y are as above.

Assignments (2)
SECURITY INTEREST Recorded Nov 17, 2015
From: SALADAX BIOMEDICAL, INC.
To: SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Reel/Frame 037126/0733 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2006
From: SALAMONE, SALVATORE J.; COURTNEY, JODI BLAKE; STOCKER, DENNIS
To: SALADAX BIOMEDICAL INC.
Reel/Frame 017542/0310 →